Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile Marcos Cruces Olivar, Allan D. Burboa, Yolanda M. Gómez

Drug-drug interactions of non-steroidal anti-inflammatory drugs with other drugs in patients with rheumatic diseases I. Peláez-Ballestasa, C. Meléndez-Mercado, A. Hernández-Garduño, J.L. Viramontes-Madrid, R. Burgos-Vargas

Quality of life of patients with rheumatic diseases Lourdes Villalobos-Sánchez, Boris Blanco-Cáceres, Javier Bachiller-Corral, María Teresa Rodríguez-Serrano, Mónica Vázquez-Díaz, Pablo Lázaro y de Mercado